Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$61.2K
1.41K shares
What this filing means
NEWHALL CHARLES W III plans to sell 1.41K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $61.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/22/2025ACC: 0001950047-25-006280
Director
Since Feb 2026
1.41K
Shares to sell
$61.2K
Approx. market value
1.41K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
In-Kind Distribution
N/A
11/16/2023
1.41KTotal acquired1.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/16/2023 | In-Kind Distribution N/A | 1.41K | — |
| Total | 1.41K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.41K
Market value
$61.2K
8/22/2025
Total
Units
1.41K
Value
$61.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/22/2025 | 1.41K | $61.2K | NASDAQ | Planned |
| Total | 1.41K | $61.2K | ||